Arrowhead Pharmaceuticals Focuses Resources on Subcutaneous and Extra-Hepatic RNAi Therapeutics
Go back to Arrowhead Pharmaceuticals Focuses Resources on Subcutaneous and Extra-Hepatic RNAi Therapeutics| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 88.88 +2.15 (2.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $86.73 | 52 Week High | $8.22 | |||
| Open | $88.00 | 52 Week Low | $3.07 | |||
| Day High | $90.21 | P/E | N/A | |||
| Day Low | $87.00 | EPS | $-1.30 | |||
| Volume | 983,043 | |||||
